--- PAGE 1 --- <BLANKLINE> Lipofectamine™ 3000 Reagent Lipofectamine™ 3000 Reagent Protocol USER GUIDE Document Part No. 100022234 Publication No. MAN0009872 Rev C.0 Protocol Outline Catalog Numbers Size: A. Plate cells so they will be 70–90% confluent at the time of transfection. L3000001 0.1 mL B. Prepare plasmid DNA-lipid complexes (recommend 2 doses of lipid). Package L3000008 0.75 mL C. Add DNA-lipid complexes to cells. L3000015 1.5 mL Contents L3000075 5 × 1.5 mL Transfection Amounts L3000150 15 mL Component 96-well 24-well 6-well ∤ Storage Conditions Store at 4°C (do not freeze). DNA per well 100 ng 500 ng 2500 ng ∤ Required ∤ Plasmid DNA (0.5–5 μg/μL stock) P3000™ Reagent per well 0.2 μL 1 μL 5 μL Materials ∤ Opti-MEM™ Reduced Serum Medium Lipofectamine™ 3000 Reagent 0.15 and 0.75 and 3.75 and Microcentrifuge tubes per well 0.3 μL 1.5 μL 7.5 μL Preparation: 10 minutes Timing Incubation: 10–15 minutes Transfection of siRNA Final Incubation: 1–3 days To transfect cells with siRNA, follow the protocol as described for DNA but Selection Lipofectamine™ Reagents do not add P3000™ Reagent when diluting the siRNA (step 3). Guide Go online to view related products. ∤ Limited Product Warranty Lipofectamine™ 3000 Reagent is a proprietary formulation Life Technologies Corporation and/or its affiliate(s) warrant their products as set forth in the Life Technologies’ General Terms Product for transfecting nucleic acids into a wide range of and Conditions of Sale found on Life Technologies’ website at www.lifetechnologies.com/termsandconditions. If you have any Description eukaryotic cells and especially designed for hard to questions, please contact Life Technologies at www.lifetechnologies.com/support. transfect cells Important Licensing Information ∤ Make DNA-Lipofectamine™ 3000 complexes in serum-free These products may be covered by one or more Limited Use Label Licenses. By use of these products, you accept the terms and medium such as Opti-MEM™ Reduced Serum Medium conditions of all applicable Limited Use Label Licenses. and add directly to cells in culture medium, in the Disclaimer ∤ presence or absence of serum/antibiotic. LIFE TECHNOLOGIES CORPORATION AND/OR ITS AFFILIATE(S) DISCLAIM ALL WARRANTIES WITH RESPECT TO THIS DOCUMENT, EXPRESSED It is not necessary to remove complexes or change/add OR IMPLIED, INCLUDING BUT NOT LIMITED TO THOSE OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, OR NON-INFRINGEMENT. Important TO THE EXTENT ALLOWED BY LAW, IN NO EVENT SHALL LIFE TECHNOLOGIES AND/OR ITS AFFILIATE(S) BE LIABLE, WHETHER IN CONTRACT, ∤ medium after transfection. TORT, WARRANTY, OR UNDER ANY STATUTE OR ON ANY OTHER BASIS FOR SPECIAL, INCIDENTAL, INDIRECT, PUNITIVE, MULTIPLE OR Guidelines CONSEQUENTIAL DAMAGES IN CONNECTION WITH OR ARISING FROM THIS DOCUMENT, INCLUDING BUT NOT LIMITED TO THE USE THEREOF. The amount of Lipofectamine™ 3000 Reagent for Corporate Entity: Life Technologies | Carlsbad, CA 92008 USA | Toll free in USA 1.800.955.6288 successful transfection varies. Start any new transfection © 2016 Thermo Fisher Scientific Inc. All rights reserved. All trademarks are the property of Thermo Fisher Scientific and its by testing the recommended two concentrations of subsidiaries unless otherwise specified. Lipofectamine™ 3000 Reagent to determine an optimum amount. Visit our product page for additional Online information and protocols. For support Resources visit thermofisher.com/support For Research Use Only. Not for use in diagnostic procedures. 10 February 2016 For support visit thermofisher.com/support <BLANKLINE> --- PAGE 2 --- <BLANKLINE> Lipofectamine™ 3000 Reagent Protocol Transfect cells according to the following table. Use the indicated volume of DNA and P3000™ Reagent with each of the two volumes of Lipofectamine™ 3000 (when performing optimization). Each reaction mix volume is for one well and accounts for pipetting variations. Scale volumes proportionally for additional wells. Timeline Steps Procedure Details (Two Reaction Optimization) For support visit thermofisher.com/support 0 yaD Seed cells to be 70–90% Component 96-well 24-well 6-well 1 confluent at transfection Adherent cells 1–4 × 104 0.5–2 × 105 0.25–1 × 106 1 yaD Diluted Lipofectamine™ 3000 Dilute Lipofectamine™ 3000 Opti-MEM™ Medium 5 µL × 2 25 µL × 2 125 µL × 2 2 Reagent in Opti-MEM™ Medium (2 tubes) – Mix well Lipofectamine™ 3000 Reagent 0.15 and 0.3 µL 0.75 and 1.5 µL 3.75 and 7.5 µL Vortex 2–3 sec Opti-MEM™ Medium 10 µL 50 µL 250 µL Diluted DNA Prepare master mix of DNA by diluting DNA in Opti- DNA (0.5–5 µg/µL) 0.2 µg 1 µg 5 µg 3 MEM™ Medium, then add P3000™ Reagent – Mix well P3000™ Reagent (2 µL/µg DNA) 0.4 µL 2 µL 10 µL Add Diluted DNA to Diluted DNA (with P3000™ Reagent) 5 µL 25 µL 125 µL each tube of Diluted 4 Lipofectamine™ 3000 Reagent (1:1 ratio) Diluted Lipofectamine™ 3000 Reagent 5 µL 25 µL 125 µL 5 Incubate Incubate for 10–15 minutes at room temperature. 10-15 Component (per well) 96-well 24-well 6-well DNA-lipid complex 10 µL 50 µL 250 µL Add DNA-lipid complex to 6 DNA amount 100 ng 500 ng 2500 ng cells P3000™ Reagent 0.2 µL 1 µL 5 µL Lipofectamine™ 3000 Reagent used 0.15 and 0.3 µL 0.75 and 1.5 µL 3.75 and 7.5 µL 4–2 yaD Visualize/analyze 7 Incubate cells for 2–4 days at 37°C. Then, analyze transfected cells. transfected cells